Global Tumor Genomics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Tumor Genomics
    1.2 Classification of Tumor Genomics by Type
        1.2.1 Overview: Global Tumor Genomics Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Tumor Genomics Revenue Market Share by Type in 2020
        1.2.3 Assays and Kits
        1.2.4 Instrument
    1.3 Global Tumor Genomics Market by Application
        1.3.1 Overview: Global Tumor Genomics Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Diagnostics and Monitoring
        1.3.3 Drug Discovery and Development
        1.3.4 Biomarker Discovery
    1.4 Global Tumor Genomics Market Size & Forecast
    1.5 Global Tumor Genomics Market Size and Forecast by Region
        1.5.1 Global Tumor Genomics Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Tumor Genomics Market Size by Region, (2016-2021)
        1.5.3 North America Tumor Genomics Market Size and Prospect (2016-2026)
        1.5.4 Europe Tumor Genomics Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Tumor Genomics Market Size and Prospect (2016-2026)
        1.5.6 South America Tumor Genomics Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Tumor Genomics Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Tumor Genomics Market Drivers
        1.6.2 Tumor Genomics Market Restraints
        1.6.3 Tumor Genomics Trends Analysis
2 Company Profiles
    2.1 Abbott Laboratories
        2.1.1 Abbott Laboratories Details
        2.1.2 Abbott Laboratories Major Business
        2.1.3 Abbott Laboratories Tumor Genomics Product and Solutions
        2.1.4 Abbott Laboratories Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Abbott Laboratories Recent Developments and Future Plans
    2.2 Agilent Technologies, Inc
        2.2.1 Agilent Technologies, Inc Details
        2.2.2 Agilent Technologies, Inc Major Business
        2.2.3 Agilent Technologies, Inc Tumor Genomics Product and Solutions
        2.2.4 Agilent Technologies, Inc Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Agilent Technologies, Inc Recent Developments and Future Plans
    2.3 Bio-Rad Laboratories, Inc.
        2.3.1 Bio-Rad Laboratories, Inc. Details
        2.3.2 Bio-Rad Laboratories, Inc. Major Business
        2.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Product and Solutions
        2.3.4 Bio-Rad Laboratories, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
    2.4 Danaher Corporation
        2.4.1 Danaher Corporation Details
        2.4.2 Danaher Corporation Major Business
        2.4.3 Danaher Corporation Tumor Genomics Product and Solutions
        2.4.4 Danaher Corporation Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Danaher Corporation Recent Developments and Future Plans
    2.5 F. Hoffmann-La Roche Ltd
        2.5.1 F. Hoffmann-La Roche Ltd Details
        2.5.2 F. Hoffmann-La Roche Ltd Major Business
        2.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Product and Solutions
        2.5.4 F. Hoffmann-La Roche Ltd Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
    2.6 Fluidigm Corporation
        2.6.1 Fluidigm Corporation Details
        2.6.2 Fluidigm Corporation Major Business
        2.6.3 Fluidigm Corporation Tumor Genomics Product and Solutions
        2.6.4 Fluidigm Corporation Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Fluidigm Corporation Recent Developments and Future Plans
    2.7 General Electric Company
        2.7.1 General Electric Company Details
        2.7.2 General Electric Company Major Business
        2.7.3 General Electric Company Tumor Genomics Product and Solutions
        2.7.4 General Electric Company Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 General Electric Company Recent Developments and Future Plans
    2.8 Illumina, Inc.
        2.8.1 Illumina, Inc. Details
        2.8.2 Illumina, Inc. Major Business
        2.8.3 Illumina, Inc. Tumor Genomics Product and Solutions
        2.8.4 Illumina, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Illumina, Inc. Recent Developments and Future Plans
    2.9 Merck KGaA
        2.9.1 Merck KGaA Details
        2.9.2 Merck KGaA Major Business
        2.9.3 Merck KGaA Tumor Genomics Product and Solutions
        2.9.4 Merck KGaA Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Merck KGaA Recent Developments and Future Plans
    2.10 Myriad Genetics, Inc. 
        2.10.1 Myriad Genetics, Inc. Details
        2.10.2 Myriad Genetics, Inc. Major Business
        2.10.3 Myriad Genetics, Inc. Tumor Genomics Product and Solutions
        2.10.4 Myriad Genetics, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Myriad Genetics, Inc. Recent Developments and Future Plans
    2.11 Pacific Biosciences of California, Inc.
        2.11.1 Pacific Biosciences of California, Inc. Details
        2.11.2 Pacific Biosciences of California, Inc. Major Business
        2.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Product and Solutions
        2.11.4 Pacific Biosciences of California, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Pacific Biosciences of California, Inc. Recent Developments and Future Plans
    2.12 PerkinElmer
        2.12.1 PerkinElmer Details
        2.12.2 PerkinElmer Major Business
        2.12.3 PerkinElmer Tumor Genomics Product and Solutions
        2.12.4 PerkinElmer Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 PerkinElmer Recent Developments and Future Plans
    2.13 QIAGEN
        2.13.1 QIAGEN Details
        2.13.2 QIAGEN Major Business
        2.13.3 QIAGEN Tumor Genomics Product and Solutions
        2.13.4 QIAGEN Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 QIAGEN Recent Developments and Future Plans
    2.14 Siemens Healthineers AG
        2.14.1 Siemens Healthineers AG Details
        2.14.2 Siemens Healthineers AG Major Business
        2.14.3 Siemens Healthineers AG Tumor Genomics Product and Solutions
        2.14.4 Siemens Healthineers AG Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Siemens Healthineers AG Recent Developments and Future Plans
    2.15 Thermo Fisher Scientific Inc.
        2.15.1 Thermo Fisher Scientific Inc. Details
        2.15.2 Thermo Fisher Scientific Inc. Major Business
        2.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Product and Solutions
        2.15.4 Thermo Fisher Scientific Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Tumor Genomics Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Tumor Genomics Players Market Share
        3.2.2 Top 10 Tumor Genomics Players Market Share
        3.2.3 Market Competition Trend
    3.3 Tumor Genomics Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Tumor Genomics Revenue and Market Share by Type (2016-2021)
    4.2 Global Tumor Genomics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Tumor Genomics Revenue Market Share by Application (2016-2021)
    5.2 Tumor Genomics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Tumor Genomics Revenue by Type (2016-2026)
    6.2 North America Tumor Genomics Revenue by Application (2016-2026)
    6.3 North America Tumor Genomics Market Size by Country
        6.3.1 North America Tumor Genomics Revenue by Country (2016-2026)
        6.3.2 United States Tumor Genomics Market Size and Forecast (2016-2026)
        6.3.3 Canada Tumor Genomics Market Size and Forecast (2016-2026)
        6.3.4 Mexico Tumor Genomics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Tumor Genomics Revenue by Type (2016-2026)
    7.2 Europe Tumor Genomics Revenue by Application (2016-2026)
    7.3 Europe Tumor Genomics Market Size by Country
        7.3.1 Europe Tumor Genomics Revenue by Country (2016-2026)
        7.3.2 Germany Tumor Genomics Market Size and Forecast (2016-2026)
        7.3.3 France Tumor Genomics Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Tumor Genomics Market Size and Forecast (2016-2026)
        7.3.5 Russia Tumor Genomics Market Size and Forecast (2016-2026)
        7.3.6 Italy Tumor Genomics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Tumor Genomics Revenue by Type (2016-2026)
    8.2 Asia-Pacific Tumor Genomics Revenue by Application (2016-2026)
    8.3 Asia-Pacific Tumor Genomics Market Size by Region
        8.3.1 Asia-Pacific Tumor Genomics Revenue by Region (2016-2026)
        8.3.2 China Tumor Genomics Market Size and Forecast (2016-2026)
        8.3.3 Japan Tumor Genomics Market Size and Forecast (2016-2026)
        8.3.4 South Korea Tumor Genomics Market Size and Forecast (2016-2026)
        8.3.5 India Tumor Genomics Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Tumor Genomics Market Size and Forecast (2016-2026)
        8.3.7 Australia Tumor Genomics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Tumor Genomics Revenue by Type (2016-2026)
    9.2 South America Tumor Genomics Revenue by Application (2016-2026)
    9.3 South America Tumor Genomics Market Size by Country
        9.3.1 South America Tumor Genomics Revenue by Country (2016-2026)
        9.3.2 Brazil Tumor Genomics Market Size and Forecast (2016-2026)
        9.3.3 Argentina Tumor Genomics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Tumor Genomics Revenue by Type (2016-2026)
    10.2 Middle East & Africa Tumor Genomics Revenue by Application (2016-2026)
    10.3 Middle East & Africa Tumor Genomics Market Size by Country
        10.3.1 Middle East & Africa Tumor Genomics Revenue by Country (2016-2026)
        10.3.2 Turkey Tumor Genomics Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Tumor Genomics Market Size and Forecast (2016-2026)
        10.3.4 UAE Tumor Genomics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer